Anti-KRT7 Polyclonal Antibody is a Rabbit antibody targeting KRT7. Anti-KRT7 Polyclonal Antibody can be used in WB,IHC-P,IHC-Fr,IF,FCM.

IgG

Human,Mouse,Rat

1. Paraformaldehyde-fixed, paraffin embedded (Rat bladder); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 min; Blocking buffer (normal goat serum) at 37°C for 30 min; Antibody incubation with (CK7) Polyclonal Antibody, Unconjugated (TMAB-01041) at 1:200 overnight at 4°C, followed by operating according to SP Kit (Rabbit) instructionsand DAB staining.
2. Paraformaldehyde-fixed, paraffin embedded (Rat bladder); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 min; Blocking buffer (normal goat serum) at 37°C for 30 min; Antibody incubation with (CK7) Polyclonal Antibody, Unconjugated (TMAB-01041) at 1:200 overnight at 4°C, followed by operating according to SP Kit (Rabbit) instructionsand DAB staining.
3. Sample:
Bronchus (Mouse) Lysate at 40 μg
Primary: Anti-CK7 (TMAB-01041) at 1/300 dilution
Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
Predicted band size: 54 kDa
Observed band size: 54 kDa
4. Sample:
Skin (Mouse) Lysate at 40 μg
Primary: Anti-CK7 (TMAB-01041) at 1/300 dilution
Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
Predicted band size: 54 kDa
Observed band size: 54 kDa
5. Tissue/cell: Human esophageal carcinoma; 4% Paraformaldehyde-fixed and paraffin-embedded;
Antigen retrieval: citrate buffer (0.01M, pH6.0), Boiling bathing for 15 min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30 min; Blocking buffer (normal goat serum) at 37°C for 20 min;
Incubation: Anti-CK7 Polyclonal Antibody, Unconjugated (TMAB-01041) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody and DAb staining.
6. Tissue/cell: human lung carcinoma; 4% Paraformaldehyde-fixed and paraffin-embedded;
Antigen retrieval: citrate buffer (0.01M, pH6.0), Boiling bathing for 15 min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30 min; Blocking buffer (normal goat serum) at 37°C for 20 min;
Incubation: Anti-CK7 Polyclonal Antibody, Unconjugated (TMAB-01041) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody and DAb staining.
7. Tissue/cell: human lung carcinoma; 4% Paraformaldehyde-fixed and paraffin-embedded;
Antigen retrieval: citrate buffer (0.01M, pH6.0), Boiling bathing for 15 min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30 min; Blocking buffer (normal goat serum) at 37°C for 20 min;
Incubation: Anti-CK7 Polyclonal Antibody, Unconjugated (TMAB-01041) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody and DAb staining.
8. Tissue/cell: human lung carcinoma; 4% Paraformaldehyde-fixed and paraffin-embedded;
Antigen retrieval: citrate buffer (0.01M, pH6.0), Boiling bathing for 15 min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30 min; Blocking buffer (normal goat serum) at 37°C for 20 min;
Incubation: Anti-CK7 Polyclonal Antibody, Unconjugated (TMAB-01041) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody and DAb staining.
9. Tissue/cell: human laryngocarcinoma; 4% Paraformaldehyde-fixed and paraffin-embedded;
Antigen retrieval: citrate buffer (0.01M, pH6.0), Boiling bathing for 15 min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30 min; Blocking buffer (normal goat serum) at 37°C for 20 min;
Incubation: Anti-CK7 Polyclonal Antibody, Unconjugated (TMAB-01041) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody and DAb staining.
10. Tissue/cell: human laryngocarcinoma; 4% Paraformaldehyde-fixed and paraffin-embedded;
Antigen retrieval: citrate buffer (0.01M, pH6.0), Boiling bathing for 15 min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30 min; Blocking buffer (normal goat serum) at 37°C for 20 min;
Incubation: Anti-CK7 Polyclonal Antibody, Unconjugated (TMAB-01041) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody and DAb staining.
11. Blank control: Hepg2 (blue)
Isotype Control Antibody: Rabbit IgG-FITC (orange);
Primary Antibody Dilution: 1 μL in 100 μL 1X PBS containing 0.5% BSA (green).
12. Blank control: A549. Primary Antibody (green line): Rabbit Anti-CK7 antibody (TMAB-01041)
Dilution: 1 μg/10^6 cells;
Isotype Control Antibody (orange line): Rabbit IgG.
Secondary Antibody: Goat anti-rabbit IgG-PE
Dilution: 0.2 μg/test.
Protocol
The cells were fixed with 4% PFA (10 min at room temperature) and then permeabilized with 20% PBST for 20 min at room temperature. The cells were then incubated in 5% BSA to block non-specific protein-protein interactions for 30 min at at room temperature. Cells stained with Primary Antibody for 30 min at room temperature. The secondary antibody used for 40 min at room temperature.
13. Blank control: Hela.
Primary Antibody (green line): Rabbit Anti-CK7 antibody (TMAB-01041)
Dilution: 1 μg/Test;
Secondary Antibody: Goat anti-rabbit IgG-FITC
Dilution: 0.5 μg/Test.
Protocol
The cells were fixed with 4% PFA (10 min at room temperature) and then permeabilized with 90% ice-cold methanol for 20 min at-20°C. The cells were then incubated in 5% BSA to block non-specific protein-protein interactions for 30 min at room temperature. Cells stained with Primary Antibody for 30 min at room temperature. The secondary antibody used for 40 min at room temperature.
14. Sample:
Lane 1: Mouse Urinary bladder tissue lysates
Lane 2: Mouse Breast tissue lysates
Lane 3: Mouse Placenta tissue lysates
Lane 4: Mouse trachea tissue lysates
Lane 5: Rat Urinary bladder tissue lysates
Lane 6: Rat Placenta tissue lysates
Lane 7: Human Hela cell lysates
Lane 8: Human Hepg2 cell lysates
Lane 9: Human Siha cell lysates
Lane 10: Human Huvec cell lysates
Primary: Anti-CK7 (TMAB-01041) at 1/1000 dilution
Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
Predicted band size: 54 kDa
Observed band size: 54 kDa

WB: 1:500-2000; IHC-P: 1:100-500; IHC-Fr: 1:100-500; IF: 1:100-500; FCM: 0.2µg/Test

Polyclonal

KLH conjugated synthetic peptide: the middle of human CK7

Human

Cytokeratins